These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 36422487

  • 1. Is the treatment of inflammatory arthritis different in sickle cell disease?
    Kimyon G, İlhan G.
    Turk J Med Sci; 2022 Jun; 52(5):1721-1728. PubMed ID: 36422487
    [Abstract] [Full Text] [Related]

  • 2. Characteristics and outcome of connective tissue diseases in patients with sickle-cell disease: report of 30 cases.
    Michel M, Habibi A, Godeau B, Bachir D, Lahary A, Galacteros F, Fifi-Mah A, Arfi S.
    Semin Arthritis Rheum; 2008 Dec; 38(3):228-40. PubMed ID: 18177923
    [Abstract] [Full Text] [Related]

  • 3. Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases.
    Silvagni E, Bortoluzzi A, Carrara G, Zanetti A, Govoni M, Scirè CA.
    BMJ Open; 2018 Sep 11; 8(9):e021447. PubMed ID: 30206082
    [Abstract] [Full Text] [Related]

  • 4. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
    van Vollenhoven RF, Ernestam S, Geborek P, Petersson IF, Cöster L, Waltbrand E, Zickert A, Theander J, Thörner A, Hellström H, Teleman A, Dackhammar C, Akre F, Forslind K, Ljung L, Oding R, Chatzidionysiou A, Wörnert M, Bratt J.
    Lancet; 2009 Aug 08; 374(9688):459-66. PubMed ID: 19665644
    [Abstract] [Full Text] [Related]

  • 5. Treatment patterns among patients with rheumatic disease (rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated arthritis (UnA)) treated with subcutaneous TNF inhibitors.
    Tymms K, Littlejohn G, Griffiths H, de Jager J, Bird P, Joshua F, Nash P, Handel M, McManus H, Butcher BE, Youssef P.
    Clin Rheumatol; 2018 Jun 08; 37(6):1617-1623. PubMed ID: 29667098
    [Abstract] [Full Text] [Related]

  • 6. Effect of anti-rheumatic treatment on selenium levels in inflammatory arthritis.
    Deyab G, Hokstad I, Aaseth J, Småstuen MC, Whist JE, Agewall S, Lyberg T, Tveiten D, Hjeltnes G, Zibara K, Hollan I.
    J Trace Elem Med Biol; 2018 Sep 08; 49():91-97. PubMed ID: 29895378
    [Abstract] [Full Text] [Related]

  • 7. The clinical application of etanercept in Chinese patients with rheumatic diseases.
    Chou CT.
    Mod Rheumatol; 2006 Sep 08; 16(4):206-13. PubMed ID: 16906369
    [Abstract] [Full Text] [Related]

  • 8. Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease: a nationwide series.
    Toussirot É, Houvenagel É, Goëb V, Fouache D, Martin A, Le Dantec P, Dernis E, Wendling D, Ansemant T, Berthelot JM, Bader-Meunier B, Kantelip B, Le CRI.
    Joint Bone Spine; 2012 Oct 08; 79(5):457-63. PubMed ID: 22088934
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept.
    Fleischmann R, Iqbal I, Nandeshwar P, Quiceno A.
    Drug Saf; 2002 Oct 08; 25(3):173-97. PubMed ID: 11945114
    [Abstract] [Full Text] [Related]

  • 10. The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease.
    Cepeda EJ, Williams FM, Ishimori ML, Weisman MH, Reveille JD.
    Ann Rheum Dis; 2008 May 08; 67(5):710-2. PubMed ID: 18079191
    [Abstract] [Full Text] [Related]

  • 11. Intra-articular therapy with methotrexate or tumor necrosis factor inhibitors in rheumatoid arthritis: a systematic review.
    Sullivan MM, Pham MM, Marks LA, Aslam F.
    BMC Musculoskelet Disord; 2021 Sep 15; 22(1):792. PubMed ID: 34525992
    [Abstract] [Full Text] [Related]

  • 12. Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics.
    Chiu YM, Chen DY.
    Expert Rev Clin Immunol; 2020 Feb 15; 16(2):207-228. PubMed ID: 31852268
    [Abstract] [Full Text] [Related]

  • 13. Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database.
    Sfikakis PP, Bournia VK, Sidiropoulos P, Boumpas DT, Drosos AA, Kitas GD, Konstantonis G, Liossis SN, Manoussakis MN, Sakkas L, Tektonidou M, Tzioufas AG, Vlachoyiannopoulos PG, Kani C, Paterakis P, Litsa P, Vassilopoulos D.
    Clin Exp Rheumatol; 2017 Feb 15; 35(4):579-585. PubMed ID: 28281458
    [Abstract] [Full Text] [Related]

  • 14. Anti-TNF Therapy and the Risk of Malignancies and Infections in Inflammatory Rheumatic Diseases - Our Experience.
    Pap M, Sapina I, Laktašić Žerjavić N, Žagar I, Kovač Durmiš K, Kalebota N, Kovačević P, Caktaš IL, Dekleva V, Birkić D, Kolar Mitrović H, Perić P.
    Psychiatr Danub; 2021 Feb 15; 33(Suppl 4):625-631. PubMed ID: 34718291
    [Abstract] [Full Text] [Related]

  • 15. Initiation of Disease-Modifying Therapies in Rheumatoid Arthritis Is Associated With Changes in Blood Pressure.
    Baker JF, Sauer B, Teng CC, George M, Cannon GW, Ibrahim S, Cannella A, England BR, Michaud K, Caplan L, Davis LA, OʼDell J, Mikuls TR.
    J Clin Rheumatol; 2018 Jun 15; 24(4):203-209. PubMed ID: 29664818
    [Abstract] [Full Text] [Related]

  • 16. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P, Auethavekiat P, Udomsubpayakul U, Janvitayanujit S.
    Int J Rheum Dis; 2009 Jul 15; 12(2):118-24. PubMed ID: 20374328
    [Abstract] [Full Text] [Related]

  • 17. Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.
    Cacciapaglia F, Anelli MG, Rinaldi A, Serafino L, Covelli M, Scioscia C, Iannone F, Lapadula G.
    Drug Dev Res; 2014 Nov 15; 75 Suppl 1():S77-80. PubMed ID: 25381986
    [Abstract] [Full Text] [Related]

  • 18. Perspective of sarcoidosis in terms of rheumatology: a single-center rheumatology clinic experience.
    Karabulut Y, Öz N, Gezer HH, Esen İ, Duruöz MT.
    Rheumatol Int; 2022 Dec 15; 42(12):2191-2197. PubMed ID: 36006458
    [Abstract] [Full Text] [Related]

  • 19. [Disease-modifying treatment for inflammatory rheumatism in sub-Saharan Africa: outcome at 6 months of 205 Senegalese patients with rheumatoid arthritis].
    Ndongo S, Pouye A, Lekpa FK, Bihéhé DM, Tiendrebeogo J, Ndao AC, Ka MM, Moreira Diop T.
    Med Sante Trop; 2012 Dec 15; 22(4):385-9. PubMed ID: 23352953
    [Abstract] [Full Text] [Related]

  • 20. Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
    Deyab G, Hokstad I, Whist JE, Småstuen MC, Agewall S, Lyberg T, Bottazzi B, Meroni PL, Leone R, Hjeltnes G, Hollan I.
    PLoS One; 2017 Dec 15; 12(2):e0169830. PubMed ID: 28225768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.